138 related articles for article (PubMed ID: 15700678)
1. [Hepatitis C virus seroprevalence in the hemodialysis unit of our hospital and prevention of transmission].
Bahçebaşi ZB; Alçelik A; Korkmaz U; Oztürk E
Mikrobiyol Bul; 2004 Oct; 38(4):489-90. PubMed ID: 15700678
[No Abstract] [Full Text] [Related]
2. [Transmission of hepatitis C virus by dialysis: myth or reality? New perspective with molecular studies].
Alvarado Esquivel C
Rev Invest Clin; 2001; 53(1):13-4. PubMed ID: 11332044
[No Abstract] [Full Text] [Related]
3. Hepatitis B and C virus in West-Central Turkey: seroprevalence in healthy individuals admitted to a university hospital for routine health checks.
Demirtürk N; Demirdal T; Toprak D; Altindiş M; Aktepe OC
Turk J Gastroenterol; 2006 Dec; 17(4):267-72. PubMed ID: 17205404
[TBL] [Abstract][Full Text] [Related]
4. [Hepatitis C virus genotypes among chronic hemodialysis patients in Dakar].
Diouf ML; Diouf B; Seck A; Raphenon G; Moreira-Diop T
Gastroenterol Clin Biol; 1999 Nov; 23(11):1261-2. PubMed ID: 10651539
[No Abstract] [Full Text] [Related]
5. Hepatitis C virus and hemodialysis.
Mehta K; Hakim A
J Assoc Physicians India; 1999 Dec; 47(12):1137-8. PubMed ID: 11225210
[No Abstract] [Full Text] [Related]
6. Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of Turkey.
Akcam FZ; Uskun E; Avsar K; Songur Y
Int J Infect Dis; 2009 Mar; 13(2):274-84. PubMed ID: 18945630
[TBL] [Abstract][Full Text] [Related]
7. The seroprevalence of anti-HCV in high-risk dialysis patients.
Bin Selm SA
Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):806-7. PubMed ID: 21743237
[No Abstract] [Full Text] [Related]
8. Seroprevalence of hepatitis B and C viruses in patients with chronic kidney disease in the predialysis stage at a university hospital in Turkey.
Sit D; Kadiroglu AK; Kayabasi H; Yilmaz ME; Goral V
Intervirology; 2007; 50(2):133-7. PubMed ID: 17191015
[TBL] [Abstract][Full Text] [Related]
9. Statement in the title of papers should be supported by the evidence presented: transmission of hepatitis C virus in southern Italy.
Greco D; Mele A
J Med Virol; 2003 Nov; 71(3):321-2. PubMed ID: 12966535
[No Abstract] [Full Text] [Related]
10. [Hepatitis C dissemination by hemodialysis: default isolation versus universal hygienic precautions (reply)].
Mauro MM; Ficaccio C
G Ital Nefrol; 2002; 19(1):82. PubMed ID: 12165951
[No Abstract] [Full Text] [Related]
11. Hepatitis C virus screening and clinical monitoring of biomarkers in patients undergoing hemodialysis.
Maia LP; Martins-Filho OA; Teixeira-Carvalho A; Speziali E; Vermhren R; Lira EF; Lima TA; Braga WS; Torres KL; Malheiro A
J Med Virol; 2009 Jul; 81(7):1220-31. PubMed ID: 19475604
[TBL] [Abstract][Full Text] [Related]
12. [Hepatitis c virus infection in dialysis: necessity of prevention and screening].
Poignet JL
Nephrologie; 1997; 18(2):39-40. PubMed ID: 9182231
[No Abstract] [Full Text] [Related]
13. Hepatitis C virus infection in patients on hemodialysis and after renal transplantation in the area of Rijeka-Croatia.
Brncić N; Vujaklija-Stipanović K; Crnić-Martinović M; Matić-Glazar D
Transplant Proc; 1996 Feb; 28(1):178. PubMed ID: 8644166
[No Abstract] [Full Text] [Related]
14. Factors associated to the prevalence of antibodies to hepatitis C virus among patients receiving hemodialysis at selected dialysis centers in Puerto Rico, 2005.
Soto-Salgado M; Pérez CM; Burgos-Calderón R; Torres EA; Suárez E
P R Health Sci J; 2009 Mar; 28(1):18-23. PubMed ID: 19266735
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of hepatitis virus antibodies in paramedical students.
Trevisan A; Morandin M; Frasson C; Di Marco L; Fabrello A; Davanzo E; Borella-Venturini M
J Hosp Infect; 2005 Nov; 61(3):272-3. PubMed ID: 16026899
[No Abstract] [Full Text] [Related]
17. Seroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan, Islamic Republic of Iran.
Amiri ZM; Shakib AJ; Toorchi M
East Mediterr Health J; 2005 May; 11(3):372-6. PubMed ID: 16602456
[TBL] [Abstract][Full Text] [Related]
18. [Markers of hepatitis C virus infection in dialysis units. A decreasing problem but still present in Argentina].
Bruch Igartúa E
Acta Gastroenterol Latinoam; 1999; 29(3):135-7. PubMed ID: 10533661
[No Abstract] [Full Text] [Related]
19. Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003.
Irani-Hakime N; Musharrafieh U; Samaha H; Almawi WY
Am J Infect Control; 2006 May; 34(4):241-3. PubMed ID: 16679184
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection in hemodialysis patients in Sudan: two centers' report.
El-Amin HH; Osman EM; Mekki MO; Abdelraheem MB; Ismail MO; Yousif ME; Abass AM; El-haj HS; Ammar HK
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):101-6. PubMed ID: 17237901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
